Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Like many of you, I 'suspect' that Dr Victor is having little to do with the day to day decisions that are made at Intellicell which makes me ask myself who is making the decisions.
On paper, he's still the CEO and therefore the 'responsible' person to sign off SEC returns and to act as a spokesperson for the few PRs that are released but that still leaves us speculating who is running the show.
What we do know is that on 21st January, a PR spoke about the development of the new flask, closely followed on 27th January with news about the Diabetes IND with Invigorcell. There's not a lot of information about Invigorcell but Dr Sandberg does have it on his LinkedIn profile.
I still ask why people would be getting involved with Intellicell if there was no substance to the situation. These guys are smarty and stand to lose more from a reputation point of view than they do financially.
I don’t buy this stuff from yesterday about ARI being something to do with research and innovation, more likely to be related to Andrews but I’m not aware that they work with adipose tissue for stem cells so who knows what smoke screens are being blown about here…
Still think the ‘perfect storm’ combination of events and PR releases is going to happen at some point which will prove the sceptics wrong…
Thoughts…
Late annual report due to be filed today or tomorrow...
Any bets???
The press release on 28 Jan 15 talked about revenues of ‘nearly $20 million or more’ so it’s possible that the FY 13/14 10k could show revenues greater than $20 million, especially when DF is ‘forecasting’ revenue for FY 15/16 to be as high as $60 million.
I agree - imagine what the combination of Andrews/Hackel/Hill/Inventiv could do as a research team and how much influence and momentum could they generate...
I would,imagine that Andrews labs are cGTP compliant - could be disastrous to his reputation if they weren't and there were problems...
Gem, remember that Dr Anz has been doing a lot of work with his old mentor in Asia over the last few years so he's probably quite experienced...
There are a few links posted of him speaking about stem cell treatment on US TV.
Thoughts...
Firstly, Shiv – wish you a speedy recovery my friend, fingers crossed that your shoulder repair works…
Now to business…
Gem, by definition, if the FDA requires a stem cell approved lab then Andrews already has one – they’re processing stem cells extracted from bone marrow so it must already be in place to meet FDA requirements!
However, if the AREF building isn’t fully completed then the Andrews Institute may only have minimal lab facilities to deliver the services that they need at the moment; I imagine the research activities that they intend to carry out will have far more extensive support facilities, including labs.
I can understand why the staff at Andrews might be a little cagey about Shiv’s questions; if there are studies ongoing then technically the treatment isn’t available at the moment, unless you happen to be a retired sportsman, with knee pain, and you’re invited to take part in the trial.
Of course if the study isn’t going ahead or has finished then technically the treatment isn’t available at Andrews.
Who knows, more assumptions and inferences but possible nevertheless…
I also remember comments a while ago about how Andrews has pulled out because of notices saying that share issues to AREF has been put on hold – if AREF didn’t technically exist or wasn’t actually functioning it would be difficult to justify the issue of shares. Perhaps the overdue 10k will give us a better insight into what’s happening…
Thought...
I think some people are getting confused about filings because the end of the IFCR financial year is 31st March and not 31st December...
We have the amended Annual Report (10k) for financial year ending 31st March 2013.
We are waiting to see the amended Annual Report (10k) for financial year ending 31st March 2014.
These are the two amended returns that DF mentioned in the press release below:
http://www.4-traders.com/INTEGRATED-FREIGHT-CORP-11291680/news/Integrated-Freight-Corp--Integrated-Freight-Will-Report-Year-Over-Year-Profitability-19776758/
We will be due to see the Annual Report (10k) for year ending 31st March 2015 which is due 90 days after the end of the financial year - in this case 29th June 2015.
PLUTO is also the name of Mickey Mouse's dawg, does that mean we're all barking mad to hold shares in Intellicell??
Woof Woof...
My background is as a military paramedic so my knowledge of the FDA is limited but I do have a few thoughts…
The easy one – ALS or Lou Gehrig’s disease is a progressively debilitating neurological condition with no known cure. The FDA could quite easily approve a study/treatment protocol using Intellicell’s extraction process to treat ALS patients as it could fall under either an Emergency Use IND or a Treatment IND. Obviously any data generated during these activities could be used towards an overall evidence case for the safety and efficacy of the extraction process.
We know that Dr Manuel Trujillo (psychiatrist) is interested in this work and has already been working with Intellicell to look at potential clinical research studies (some reports also say that his sister has ALS) and there are also some slides published of a presentation that Dr Victor delivered at the 2014 Marcum Conference which showed QEEG scans pre and post treatment with stem cells (don’t know if it was SVFCs but I personally think not):
https://www.scribd.com/doc/227057734/Intellicell-Biosciences-Marcum-Conference-PDF
As I’m not that knowledgeable on FDA processes and regulations I don’t know what other aspects of FDA regulations may be met with a study into SVFC treatment of ALS.
As regards the safety side of things, there may be sufficient evidence from all of the treatments that have been carried out to support a safety claim that the FDA require (provided of course sufficient notes have been kept) without going back to animal studies. The only published issues seem to be in relation to local infections at wound sites…
You also raise an interesting point here, I’ve been thinking of Andrews working with the FDA, what if we throw Hill and Inventiv into the pot as well – FDA working with a world renowned orthopaedic/sports injuries guru plus a well thought of clinical research organisation plus that CROs ex-CEO; that would be a powerful combination IMO, one that the FDA would might be happy to work with (as they’re still on the learning curve in relation to stem cell therapies and biologics).
I personally think this is where we are at the moment and that there’s a collaborative effort going on – the out of the blue comment about the Hielscher flask suggest a hiccup but one which has been overcome, and a hiccup suggests work in progress.
From a European Patent perspective, the amended reports were filed in January so there could be an outcome in the near future (perhaps even mentioned in the now overdue 10K) but you’re right, this doesn’t stop Intellicell from acting on an international front and the little trip to the UAE could be the next move in the game.
If we do have to go down the new drug route without any FDA exemptions, there is nothing wrong with starting trials in Europe as it is quicker than the US (I’m following another biotech which is doing just that).
Corporate structure has been talked about by plenty of people, I’m not sure what will happen; if financing is on board, those decisions have probably been made already…
Just got to wait for the 10K and see what happens from there but I do believe that this is still a potentially game changing technology however badly the company has been mismanaged…
Anyone have any guesses when the reworked FY 13/14 annual report will hit the streets – must be about due as the FY 12/13 report came out almost a month ago...
Hi Corey,
Welcome back, you’ve not missed much…
There’s been no news at all, other than the stuff you may already know about (the flask with Hielscher Ultrasonics and the Invigorcell IND for Diabetes).
There’s been no update on the YA Global financing agreement or other investors through Dawson James and Dinosaur.
We’ve heard nothing about Andrews either (other than a comment a couple of months ago saying that there might be a report due in March).
However, a number of people, myself included think that there’s a lot going on behind the scenes and that the funding is probably in place once Andrews/FDA/EU patent issues are resolved and that is precisely the reason we’ve heard nothing. The ultrasound flask with Hielscher could be an improvement to the process or FDA input to enhance safety but that’s just speculation.
A few people or organisations) out there look to be buying up big blocks of shares so there’s a number of us think that there’s some accumulation going on –why, we don’t know but it’s not beyond the realms of possibility that these parties know what’s happening and are buying now while the price is at rock bottom.
The 2014 10K is now overdue but no-one’s surprised as it follows the pattern of previous filings and the NT 10K stated that there were no significant changes in results of operations from last year. However, that doesn’t mean that there won’t be anything to report as there could finally be some news to report and this might be the time to release (or not)…
Understandably there are a lot of people starting to get a little p***ed at the situation but there’s nothing we can do.
Can’t really say more than that as there’s not much else to say…
Thoughts…
OMG, what a surprise... NOT
Question is, will they file in 15 days time - not convinced they will...
Good God, of course the British are here man, don't think we'd let these damn colonials have all of the fun...
Good God, of course the British are here man, don't think we'd let these damn colonials have all of the fun...
Lot's of strategies COULD be done, everyone's waiting to see what WILL be done to get us out of this mess...
Don't necessarily need a new entity to remove the CEO, could be done as part of an investment deal - if they were to spin off a separate entity, he could insist on being in charge of that as well so nothing's guaranteed. Just need to get his ego in check...
Let's just wait and see what happens...
I do wonder if they are going to file imminently as they haven't bothered to file a late notification, but it makes little sense just before Easter unless it's a deliberate action to possibly cause a gap up on Monday when markets open...
Not holding my breath...
Don't know about the separate entity, it's one way of isolating Intellicell but it doesn't remove the problem.
I personally think they should use Intellicell and work with what they have; if it works as advertised, there will be multiple revenue streams coming on line, especially if the European patent is awarded.
There have been some large, multi-million share purchases going on over the last couple of months (at the moment it can't be conversions as there's NO BID so no-one is selling other than the MMs. Point is someone is accumulating, we don't know who or why but it is feasible that it is an investor buying shares to eventually retire them which lessens the need for RS AND helps get the shares under control.
This could be an investor playing the long game here, recognizing that there's more to be had by staying with Intellicell for the journey and by removing shares from circulation. Anyone have an idea what the float is, there could be a lot locked up which could make a price movement go quickly. We just don't know...
Remember that if minimal manipulation and safety/efficacy are proved, this opens the door for everyone else doing INDs to use our extraction process which equals lots more labs plus revenue for each patient - on multiple INDs that could be a lot of revenue very quickly...
thoughts???
Agree 100% Trebeg...
Hi HAE12, good question which I'll try and reply...
Not really an uneasiness about the process - I believe it works in principal - the Millipore study, Dr Khalpey's cardiac study etc tells me that there's something to it. Can it be improved or made safer/less manipulative, probably and I think that's what's happening now, especially with the news of the sonification flask/reactor)
I believe the PPS is so low because of poor management (although I don't believe the Doc made deliberate choices to damage the company)- he made a couple of poor investment decisions which have had a big knock-on effect.
I think the other big issue with the PPS is that it was in a position where it could be manipulated down quite easily by others (we probably know who they are but proving it is much more difficult) and it will take a number of big PRs to get it moving up again, passed the point where it can be dropped back down to current levels.
The silence, historically they've been quiet and filed late but that's not a problem as long as they do file - late filing doesn't mean there's nothing to say, just poor management...
Remember they didn't have to have those annual reports redone at cost to the company did they, unless it was to satisfy potential investors.
We don't know that there aren't investors already lined up, terms agreed just waiting to sign on the dotted line, once Andrews/FDA reports are released. If I were an investor, I would tie in the terms of any agreement NOW before these reports are published - it gives me a stronger hand to negotiate with, rather than wait until things improve and there are more investors lining up, all jostling to get in on the act.
Why would they increase the AS and preferred shares if there were no investors sniffing around, that's the only logical reason to increase to 250Bn, that level has no relevance to CDs. (By the way I don't think a RS is on the cards YET)
As I've said on more than one occasion, I think there are too many examples where this extraction process has worked AND produced significant results for it to be BS (think cardiac study, orthopeadic cases, MS case, ALS with Dr Trujillo's sister, head injury cases with military veterans and the list goes on).
Why are there a number of different INDs in the pipeline? Why are Andrews/Invigorcell/Trujillo interested if this is a POS - they have too much of a reputation to lose?
Am is frustrated at the lack of progress, YES, but I believe it will come out in the end and I'm going to be around when it does...
Thoughts???
He he...
The sad thing is we simply don't know WTF is happening with this company.
I personally believe there are things brewing away related to Andrews and/or the FDA but we don't know. All of this talk about does it actually work is BS because there is sufficient evidence (not just from Intellicell) to suggest that we're onto something here, a way of extracting stem cells which gives greater yields of usable stem cells, quicker, cheaper and less invasive than other methods.
I'd like to think that we're getting close, given earlier comments about Andrews etc; plus we've not heard anything about the YA Global maturity so perhaps they've been talking with Intellicell and getting them to hold off but again, we don't know because of the comms blackout.
I'm not even concerned about the filing because, as we've seen before, they're notoriously bad at this kind of stuff - news will happen when it happens. All is see is a lot of shareholders becoming more and more impatient when actually, there's nothing we can do but wait. Maybe it will all work out in the end, maybe not but either way, news will come when it comes...
I still believe in this thing, there's too much going for it to think otherwise and I like to think I'm realistic about things...
Per Ardua Ad Astra...
Could mean that they're about to file in the very near future...
I think they'll hold all PRs and release them in a co-ordinated way to maximize the momentum and upward movement of the SP.
I truly believe the financial arrangements have been discussed and negotiated and all that we're waiting for are signatures on papers as and when there is information about the Andrews pre-IND study plus the FDAs position and it wouldn't surprise me if Andrews and the FDA are working in collaboration.
If this is a better way for him and his guys to extract stem cells for treating his patients, it's in his interest to get the best deal that he can with the FDA.
From an investor's point of view, I would want to nail down the terms of any financing deal BEFORE all of this news came out as it gives me a stronger negotiating position. Imagine if I (as an investor) waited until (hypothetically) we hear that Intellicell's process is considered minimally manipulated and does produce higher numbers of viable cells etc, it gives Intellicell a better position to negotiate from.
That's why I believe the negotiations are already underway or even finalized and we're just waiting for the results of studies and discussions.
I think revenue growth in the US is a slow burning fuse but it will grow exponentially once all of the INDs begin and we start to see results; same in Europe as well but I agree with many who say let's go after the guys in Australia and the Far East and who knows, maybe the Middle East will start to generate revenue...
Thoughts...
I actually said "...failure to do so might be a valid reason for dismissal..." not that it definitely would as I don't know US business law very well...
If you read the article there are comments that Miller and Salvani made but failed to substantiate by providing proof or evidence - if I was the judge I certainly wouldn't look at that favourably and if I ordered someone to pay a bond of $100,000 and the payment wasn't made, I would dismiss the case.
Can't speak for the judge of course, just myself...
As for compensation, I personally wouldn't award any as it would be difficult to prove that Intellicell had been materially damaged specifically by the allegations of misconduct. I imagine if it was dismissed, Miller and Salvani would be out of pocket enough so I probably wouldn't penalize them anymore but as I said, I'm not a judge...
Thoughts???
Don't know if they complied but failure to do so might be a valid reason for dismissal by the judge...
Listen, on 27th January they released information about an IND with Invigorcell for Diabetes and what happened to the SP - Nothing, Nada, Zip, so why would a much less important release from the company do anything to the SP?
I'll say it again, the SP is so low, only a prolonged campaign of press releases and positive information will help this company move upwards to what it should be.
Remember also that flippers and others are doubling their investment when it moves from 1 to 2 so they're in no hurry for this to change.
When conditions are right (FDA/Andrews/Legal/Investments etc etc, this company will have the energy to start the journey up to a respectable price and not before.
IMHO these individual bits of information from our own DD will do nothing, it will take BIG stuff (perhaps confirming what our own DD is saying) to move the needle on this one but I'm not concerned, it's happening, we just don't know what is going on.
Yes, this is frustrating but I can sleep at night knowing that the BOD and the Doc all want the same thing as us - higher share prices and I believe it will happen at some point in the ear future, there's too much stuff going on around Intellicell to speculate otherwise...
Thoughts???
Found an update on the Miller and Salvani vs Victor and 'everyone else at Intellicell' lawsuit dated 2 March 15, that’s the one that you're referring to Gem, I think...
Miller and Salvani were ordered by the judge to pay $100,000 as a bond within 14 days (by the 16th March) but I don’t know whether they did or not; if not, what would happen – case dismissed???
http://docs.justia.com/cases/federal/district-courts/new-york/nysdce/1:2014cv01819/424681/101
Possibly another reason for the silence, why would you release this one small piece of news for the SP to move up and then move straight back down the same day (my opinion folks). Better to wait for a number of different things to gain momentum to get this company unstuck or out of the mud and to include in the annual report due soon…
Maximising the momentum that any news releases can give has to be paramount in their minds and if I were in the same position, I’d probably do the same…
Another piece of the puzzle falls into place???
What's the point in hiring someone to manage press releases and news when there are none - money wasted...
He'll be brought on board as and when there is something to tell - we believe it's coming from all of the snippets of information that we have been fed...
Different sides of the same point - no-one was able to sell because the MMs weren't buying - they were the only ones who were selling...
Same difference, maybe I didn't explain it fully...
Either way, people are still willing to buy large blocks of shares from the MMs - dangerous if this is the flying turd that people claim it is...
Nope, just an assumption based on the fact that there's nothing showing on the Bid side of my Level 2.
Therefore I am assuming that the only people selling are the MMs.
Have no intention of selling either, am waiting for it to move north...
Seems odd to throw away that kinda cash...
Unless you have inside information and know what is really happening...
Seems odd to throw away that kinda cash...
Unless you have inside information and know what is really happening...
Nobody is able to sell but there's been 138 MILLION shares bought today, by who I wonder...
Perhaps there are some people out there who know what's really happening and are taking this opportunity...
Why are we still asking whether the process works?
There's enough anecdotal evidence out there, posted by respected doctors in medical journals to support the validity of the extraction process and the benefits from using SVFCs (think Dr Khalpey in the American Journal of Medicine).
The bigger issue is the FDA input around patient safety and the 'minimal manipulation' debate.
The only thing I can ever remember seeing is around infections at injection sites (I'm an ex-military medic and I've seen a lot of these types of localized infections) which are generally as a result of poor cannulation or injection technique and skin cleanliness practices.
I can't ever remember reading about allergic reactions - why should they be, the SVFs come from the patient...
The patent discussions are a different issue but again, I've read the revised patent application material and it's a whole lot cleaner than the original submission, so fingers crossed...
Then there's the reactor - why even bother if there are issues with the efficacy of the SVFs???
I think the time is being taken to perfect the process and gain FDA agreement on and when the time is right, we'll hear something...
Yes I do, whether I am delusional or not remains to be seen...
Has there been bad management by the good doctor - YES
Has the board done what they should have done - PROBABLY NOT
Has the communication from Intellicell been timely - NO
It's always easy to bash a stock and its supporters when it's DOWN but that doesn't mean it's OUT.
If the extraction process works, this company still has a future, FDA approval regarding minimal manipulation would be great but it's not imperative, the safety issue is and I guess that's what they're working on at the moment with Andrews.
Things can change quickly in pennyland so let's not forget that.
Yes, maninthechair, I do talk BS sometimes,that's what we have in the free world, just as you can say that about me - but you know what, I don't give a damn what you think of me, it won't keep me awake at night and when this baby does eventually fly, I'll be the one with the tall drink and a BIG smile on my face...
SVFC Long and Strong...
I would speculate that it is not retail investors like you or I but either a larger investment house or maybe even someone intending to invest large sums into Intellicell via Dinosaur or Dawson James.
Any investment deal could give them controlling rights to some of the preferred stock and they are topping up with common stock by buying at these ridiculously low prices; this will save an absolute fortune if bought now when compared to a buyback option at some point in the future.
Remember we've seen quite a few of these large buys so someone's interested; if this is the case, they could potentially be holding as much as 1B shares...
Thoughts...
Morning campers and greetings from across the pond from the European chapter of the Steven Victor Fan Club (SVFC)...
Interesting discussions that you're all having and I thought I'd throw my thoughts in as well...
So I'm a long and currently down $16K but I'm not giving up on all hope just yet.
In my head there are too many things going for this process and therefore the company to become defeated - I agree with Gem that the new reactor is as a result of discussions with the FDA.
I'm nor surprised there's nothing from Andrews yet, he will want to make sure that this process and treatment really works before he openly supports it but he's still listed as an adviser on the Intellicell website and if that wasn't the case, it would be off there pretty damn quickly.
Look at all of the other individual cases where Intellicell has been involved, think increased cardiac function on a patient with chronic cardiac failure for example and the list goes on.
I believe that funding is already in place and will be fully signed off when the European patent and Andrews issues are resolved and then we'll have a new IR firm coming onboard as well.
I believe that the legal case at the moment will be resolved with an out of court settlement, once the SP starts to rise, so again, I don't see it as a big threat.
I understand everyone's frustration, I'm there too but we can't do anything about it so let's try and stay positive because it's healthier to do so. The SP might be low and there may be issues with 'NO BID' etc but people are still buying shares-42M shares traded yesterday, not a lot in monetary terms but trades nevertheless...
Yes, there's a dark side to what's happening which pleases the pessimists, thank goodness I'm not one of them - I choose to stay focused on what the positive outcome could be and will still be around when it happens - LONG AND STRONG SVFC...
Have a great day ladies and gents and stay safe...
Per Ardua Ad Astra...
Hoping for the FY 13/14 financials and latest acquisition news this week (before the end of the month which is next Tuesday) then we’re all set up for the financials for FY 14/15 which should be really interesting…
See this moving up quickly in the next few weeks...
GM all and greetings from across the pond...
Just wondering what Mr Krivulka and Dr Sandberg from Invigorcell might be up to as part of the Diabetes IND which was mentioned in the press release on January 27th...
Although I can't find too much information on Invigorcell, both od these guys are BIG players in pharmaceuticals or Endocrine/ Diabetes disorders so they clearly know what they're doing...
Thoughts
I would say the FDA safety concerns. If you wanted to increase the number of cells, you could consider increasing the amount of lipoaspirate - we're only talking about 60mls at the moment, that's not a lot...
You’re right to give a balanced point of view but I’d like to challenge you on some of your comments Gem…
Firstly, this is the pre-IND, which in my head, is all about SVF preparation, protocols, quality control and patient safety concerns before we even look at any kind of illness, injury or medical condition.
In order to begin any kind of study, there would need to be a way for them to isolate the cells so there’s probably been some sort of lab set up which will require FDA inspection and assessment of protocols and practices etc.
Perhaps the lab techs at the Andrews Institute have found a way to enhance the yield (remember the Roche subsidiary that confirmed the numbers of cells so the existing process seems to work already) by suggesting the new reactor (the release in January suggested that Hielscher had ‘developed’ – past tense, the reactor) and perhaps it’s already in use – Intellicell aren’t known for their timely press releases so there’s a strong possibility that it’s already in service…
The flip side is that the reactor might offer a slightly different way of preparing the SVFs which is more favourable for the FDA – remember that they’re still learning about the use of biologics and seem to be writing the manual as they go along (this also makes it easier for Andrews to influence any changes if he feels that it’s appropriate – it would take a brave FDA person to challenge Andrews I think).
The anecdotal evidence from all of the other one-off trials suggests that the process works, there are sufficient cells and that patient recovery is enhanced through using cells prepared by the Intellicell process
Legal issues – possibly I don’t know enough to comment…
I’m not entirely sure we’ll see too much in the annual report due out shortly but I think this study is way bigger than just Intellicell, this has the ability to impact every other research study using stem cells as if proved successful, it could become the preferred method of stem cell production because of the benefits of producing in this way…
You’re absolutely right Gem, there are other interests that they don’t seem to be exploiting (such as the Far East – Intellihealth and Chaum to name but two); but we don’t know because of the silence…
For example, we don’t know that both of the above haven’t been actively using the our stem cell extraction process and quietly putting $2500 per shot into a bank account; Intellicell would only have to declare the earnings if they are reimbursed and move the income into the US – speculation I know but there could be a pot of money sitting in a Thai or Korean bank account waiting to be declared or recently moved over and will be declared on the annual report due out soon.
My gut feeling is still the ‘perfect storm’ combination when they will wait until things are in place and release a series of well timed PRs which will move the share price from where it is now to penny land.
Imagine the interest if you had: major capital investment confirmed, minimal manipulation confirmed, amended/quicker IND process, positive results from Andrews, multiple INDs starting, European patent granted, international revenues (possibly including the Middle East if the Doc’s recent trip was successful) – again speculation but not impossible is it? We may already have a European patent but are keeping quiet until the report is out…
My biggest concern is about flipping, any sign of a move up and a lot of people will sell to recoup their investment – hopefully many have already gone but the comments I read on IH tells me otherwise; as the price keeps rising, others will get in and out to make a quick dollar and the momentum could be lost…
All this talk about no-bid, absolute rubbish, I see buys yesterday of 10M, 20M and 40M so someone’s accumulating (although 40M shares only costs $4k) and there was a total of 103M shares traded yesterday, most of them buys…
Lots of speculation here but why not, it’s just as feasible as anything else that I read and the silence from the company tells me something could be happening. I think there’s been some discussions with YA Global and others about what is happening in terms of the CDs and that’s why there’s been no noise.
Thoughts anyone???
That's just it though pennyboy, as MB25 has said, they can’t issue that many and they have no intention of doing so because it would wreck this company.
The remaining 240Bn shares are there for protection; investors would insist on an issue of the preferred shares because whoever holds the preferred shares, controls the remaining 240Bn normal shares.
They don’t have to be issued, they just have to control them to prevent hostile actions or takeovers against the BOD and other major investors.